The global market for transcatheter aortic valve replacement (TAVR) is seeing exponential growth in both developed and emerging markets. Growth in the decade up to 2035 is expected to be significant, aided by demographic trends and technological innovations. Edwards Lifesciences is a leader in the global TAVR market, and the company reported 8.9% year-on-year growth in TAVR sales for the second quarter (Q2) of 2025, with this positive trend continuing into July 2025.

Early reports from GlobalData, consisting of data from a panel of 2,600 US medical facilities, suggest that Edwards Lifesciences continued to see sales momentum in July 2025, with its SAPIEN 3 product lines making up a large share of sales. The company currently holds more than 60% of the global TAVR market share and 75% in the US, according to GlobalData estimates.

TAVR is indicated for patients with severe symptomatic aortic stenosis, a condition characterised by narrowing of the aortic valve tissue, often due to calcification that builds with age. The prevalence of aortic stenosis rises sharply with age, and demographic shifts will play a key role in driving demand. The United Nations projects that the number of individuals aged 80 and above will triple by 2050, driving TAVR demand.

According to GlobalData, the TAVR market is projected to see a compound annual growth rate (CAGR) of 8% worldwide between 2024 and 2034, with the US market forecast to grow at 6% CAGR during the same period.

TAVR offers several advantages over surgical aortic valve replacement (SAVR). TAVR is minimally invasive, which results in shorter recovery times and is less intensive on patients. TAVR results in patient survival and improvement that is as good as or better than that of SAVR.

More than 500,000 procedures have been performed in more than 70 countries. TAVR is quickly developing from a challenging procedure to a standardised one, as more physicians are being trained in this technique globally.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData